S. Loeckermann

Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.

O. Paul, P. Ruther, T. Magin, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.

T. Bley, R. Fässler, M. Erlacher, 2008, The Journal of clinical investigation.

Eruptive xanthomas in association with metabolic syndrome

M. Braun‐Falco, S. Loeckermann, Markus Braun-Falco, 2010, Clinical and experimental dermatology.

Facial rash in an infant

A. Schwieger-Briel, S. Loeckermann, 2015, Journal of paediatrics and child health.

Conditional collagen VII inactivation allows analysis of anchoring fibril stability and function in vivo and reveals a major role of fibroblasts in collagen VII expression

R. Fässler, L. Bruckner-Tuderman, J. Kern, 2009 .